Found: 25
Select item for more details and to access through your institution.
Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Erstlinientherapie beim fortgeschrittenen Nierenzellkarzinom : Eine randomisierte Phase-II-Studie zur Untersuchung einer frühzeitigen Therapieumstellung von Tyrosinkinaseinhibitoren auf Nivolumab im Vergleich zu einer fortgesetzten Tyrosinkinaseinhibitortherapie bei Patienten mit fortgeschrittenem oder metastasiertem Nierenzellkarzinom und stabiler Erkrankung nach 3‑monatiger Behandlung (NIVOSWITCH) – AN 38/15 der AUO.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Stellenwert der sonographisch kontrollierten perkutanen Stanzbiopsie in der Diagnostik von Weichgewebstumoren.
- Published in:
- Der Orthopäde, 2013, v. 42, n. 11, p. 941, doi. 10.1007/s00132-013-2135-8
- By:
- Publication type:
- Article
Arzneitherapie solider Tumoren.
- Published in:
- Der Internist, 2014, v. 55, n. 10, p. 1220, doi. 10.1007/s00108-014-3553-3
- By:
- Publication type:
- Article
Aktualisierte S3-Leitlinie Nierenzellkarzinom.
- Published in:
- Die Urologie, 2024, v. 63, n. 5, p. 439, doi. 10.1007/s00120-024-02328-0
- By:
- Publication type:
- Article
Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Sunitinib re-challenge in advanced renal-cell carcinoma.
- Published in:
- British Journal of Cancer, 2014, v. 111, n. 6, p. 1047, doi. 10.1038/bjc.2014.214
- By:
- Publication type:
- Article
Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC).
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 12, p. 2998, doi. 10.1038/bjc.2013.662
- By:
- Publication type:
- Article
Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis.
- Published in:
- British Journal of Cancer, 2012, v. 106, n. 9, p. 1475, doi. 10.1038/bjc.2012.89
- By:
- Publication type:
- Article
Neue Therapieansätze und Studienübersicht beim metastasierten hormonsensitiven Prostatakarzinom.
- Published in:
- Die Urologie, 2023, v. 62, n. 4, p. 369, doi. 10.1007/s00120-023-02046-z
- By:
- Publication type:
- Article
Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC).
- Published in:
- Medical Oncology, 2016, v. 33, n. 7, p. 1, doi. 10.1007/s12032-016-0794-0
- By:
- Publication type:
- Article
Exploring long-term cancer survivors' care experiences and unmet needs: protocol for a qualitative study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12527-9
- By:
- Publication type:
- Article
Prädiktive Biomarker in der onkologischen Uropathologie.
- Published in:
- Der Pathologe, 2019, v. 40, n. 3, p. 264, doi. 10.1007/s00292-019-0606-3
- By:
- Publication type:
- Article
Topotecan plus cyclophosphamide in adults with relapsed or refractory pediatric-type sarcoma: a retrospective analysis from the German Sarcoma Medical Oncology Group (AIO).
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1115, doi. 10.1007/s10637-015-0267-x
- By:
- Publication type:
- Article
Pemetrexed in patients with refractory soft tissue sarcoma: A non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 1, p. 167, doi. 10.1007/s10637-012-9840-8
- By:
- Publication type:
- Article
A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A phase i study of recombinant human interleukin-21 (ril-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (rcc)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group.
- Published in:
- World Journal of Urology, 2022, v. 40, n. 10, p. 2381, doi. 10.1007/s00345-022-04015-1
- By:
- Publication type:
- Article
Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms.
- Published in:
- World Journal of Urology, 2017, v. 35, n. 4, p. 641, doi. 10.1007/s00345-016-1903-6
- By:
- Publication type:
- Article
Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?
- Published in:
- World Journal of Urology, 2016, v. 34, n. 7, p. 909, doi. 10.1007/s00345-015-1707-0
- By:
- Publication type:
- Article
Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients.
- Published in:
- World Journal of Urology, 2011, v. 29, n. 3, p. 355, doi. 10.1007/s00345-010-0642-3
- By:
- Publication type:
- Article
Molekulare zielgerichtete Therapie und Immuntherapie des Prostatakarzinoms.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Risikoadaptierte Therapie des metastasierten Nierenzellkarzinoms.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molekulares Tumorboard – Nierenzellkarzinom.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Risikoadaptierte (Immun‑)Therapie beim Nierenzellkarzinom.
- Published in:
- 2018
- By:
- Publication type:
- journal article